Orchid Pharma Limited

NSE:ORCHPHARMA BSE:ORCHPHARMA

HealthcarePharmaceuticals & Biotechnology

₹990.0

-0.7%1 Oct close

Mkt cap

₹5,019 Cr

Watch Alert Compare

Quarterly Annual

Year ends (Mar) · % of equity

Holder (%)	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	90%	89.96%	69.84%	69.84%	69.84%
	0%	0.81%	1.96%	2.69%	0.87%
	0%	2.62%	17.73%	20.1%	20.25%
Government	0%	0%	0%	0%	0%
	10%	6.61%	10.47%	7.37%	9.04%
No. of shareholders	—	—	—	—	35,118

Promoter holding down 20.16 percentage points since Mar 2022. One column per financial year, taken from the register filed at that year end.

3 deals · 28 Nov 2023 – 30 May 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
30 May 2025	UTI MUTUAL FUND	Bulk	NSE	Buy	3,66,507	₹615.37	₹22.55 Cr
28 Nov 2023	DHANUKA LABORATORIES LIMITED	Bulk	BSE	Sell	13,00,000	₹571.28	₹74.27 Cr
28 Nov 2023	UTI MUTUAL FUND	Bulk	BSE	Buy	4,45,000	₹571.00	₹25.41 Cr

1–3 of 3

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Ram Gopal AgarwalNon-Executive - Non Independent Director-Chairperson
Mr. Manish DhanukaExecutive Director-MD
Mr. Mridul DhanukaExecutive Director
Mr. Arjun DhanukaNon-Executive - Non Independent Director
Mr. Dharam VirNon-Executive - Independent Director
Mr. Manoj Kumar GoyalNon-Executive - Independent Director
Ms. Shubha SinghNon-Executive - Independent Director
Ms. Tanu SinglaNon-Executive - Independent Director
Mr. Sunil Kumar GuptaChief Financial Officer
Mr. Kapil DayyaCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Orchid Pharma Limited

Annual record

Bulk & block deals

Board and management